Sivamaruthi, B.S.; Raghani, N.; Chorawala, M.; Bhattacharya, S.; Prajapati, B.G.; Elossaily, G.M.; Chaiyasut, C.
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease. Biomedicines 2023, 11, 2587.
https://doi.org/10.3390/biomedicines11092587
AMA Style
Sivamaruthi BS, Raghani N, Chorawala M, Bhattacharya S, Prajapati BG, Elossaily GM, Chaiyasut C.
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease. Biomedicines. 2023; 11(9):2587.
https://doi.org/10.3390/biomedicines11092587
Chicago/Turabian Style
Sivamaruthi, Bhagavathi Sundaram, Neha Raghani, Mehul Chorawala, Sankha Bhattacharya, Bhupendra G. Prajapati, Gehan M. Elossaily, and Chaiyavat Chaiyasut.
2023. "NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease" Biomedicines 11, no. 9: 2587.
https://doi.org/10.3390/biomedicines11092587
APA Style
Sivamaruthi, B. S., Raghani, N., Chorawala, M., Bhattacharya, S., Prajapati, B. G., Elossaily, G. M., & Chaiyasut, C.
(2023). NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer’s Disease. Biomedicines, 11(9), 2587.
https://doi.org/10.3390/biomedicines11092587